Suven Pharmaceuticals get final approval to amalgamate Cohance Lifesciences
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Announces Rs. 317 crore investment in new recycling plant
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
Subscribe To Our Newsletter & Stay Updated